Phosphorylated nuclear DICER1 promotes open chromatin state and lineage plasticity of AT2 tumor cells in lung

Raisa A Reyes-Castro1,2,3, Shin-Yu Chen1, Jacob Seemann1

  • 1Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Science Advances
|July 26, 2023
PubMed

Insights

Phosphorylated DICER1 in the nucleus drives advanced lung cancer progression in mice, independent of microRNAs and EMT. This nuclear DICER1 reprograms tumor cells by altering chromatin, promoting a lineage shift that contributes to tumorigenesis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • The KRAS/ERK pathway influences DICER1 phosphorylation and nuclear translocation, contributing to tumorigenesis.
  • The precise mechanisms by which phosphorylated DICER1 (phospho-DICER1) drives tumor progression are not fully understood.
  • DICER1's canonical roles involve microRNA (miRNA) regulation and epithelial-to-mesenchymal transition (EMT).

Purpose of the Study:

  • To investigate the role of phospho-nuclear DICER1 in late-stage lung tumor progression.
  • To elucidate the mechanisms by which phospho-nuclear DICER1 promotes cancer, independent of canonical miRNA and EMT pathways.
  • To identify the molecular components and cellular processes involved in phospho-nuclear DICER1-mediated lung cancer progression.

Main Methods:

  • Utilized a mouse model with oncogenic Kras to study lung tumor progression.
  • Analyzed chromatin compaction and gene expression in murine AT2 tumor cells.
  • Investigated the expression of phospho-nuclear DICER1 and gastric genes in human lung adenocarcinoma (LUAD) samples.
  • Characterized a multimeric chromatin-DICER1 complex involving Mediator complex subunit 12, CBX1, and MACROH2A.1.

Main Results:

  • Phospho-nuclear DICER1 promotes late-stage tumor progression in a Kras-driven mouse model, independent of miRNAs and EMT.
  • Altered chromatin compaction and expression of gastric genes were observed in advanced murine lung tumors.
  • Tumor cells exhibited a lineage transition from alveolar to endodermal states.
  • Human LUADs with advanced disease showed co-expression of phospho-nuclear DICER1 and gastric genes.

Conclusions:

  • Phospho-nuclear DICER1 drives lung cancer progression through lineage reprogramming of AT2 tumor cells.
  • This reprogramming involves altered chromatin structure and the formation of a chromatin-DICER1 complex.
  • The findings reveal a novel, non-canonical mechanism for DICER1 in mediating lung cancer progression and suggest potential therapeutic targets.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K